# GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

> **NCT02179645** · PHASE1 · COMPLETED · sponsor: **Glenmark Pharmaceuticals Ltd. India** · enrollment: 76 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GRC 27864
- **DRUG:** Celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02179645
- **Lead sponsor:** Glenmark Pharmaceuticals Ltd. India
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2014-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02179645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02179645, "GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02179645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*